UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 177

Sortiert nach

Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels

Atherosclerosis, 2012-02, Vol.220 (2), p.381-386

2012

Link zum Volltext

Verfügbarkeit prüfen

LOX-1, OxLDL, and Atherosclerosis

Mediators of Inflammation, 2013-01, Vol.2013, p.152786-12

2013

Link zum Volltext

Verfügbarkeit prüfen

Vascular inflammation and low‐density lipoproteins: is cholesterol the link? A lesson from the clinical trials

British journal of pharmacology, 2017-11, Vol.174 (22), p.3973-3985

2017

Link zum Volltext

Verfügbarkeit prüfen

Long pentraxin 3, a key component of innate immunity, is modulated by high-density lipoproteins in endothelial cells

Arteriosclerosis, thrombosis, and vascular biology, 2008-05, Vol.28 (5), p.925

2008

Link zum Volltext

Verfügbarkeit prüfen

Treating high density lipoprotein cholesterol (HDL-C): quantity versus quality

Current pharmaceutical design, 2013, Vol.19 (21), p.3841

2013

Link zum Volltext

Verfügbarkeit prüfen

Post-prandial endothelial dysfunction in hypertriglyceridemic subjects: Molecular mechanisms and gene expression studies

Atherosclerosis, 2007-08, Vol.193 (2), p.321-327

2007

Link zum Volltext

Verfügbarkeit prüfen

Effects of PCSK9 variants on common carotid artery intima media thickness and relation to ApoE alleles

Atherosclerosis, 2010-01, Vol.208 (1), p.177-182

2010

Link zum Volltext

Verfügbarkeit prüfen

Targeting PCSK9 for hypercholesterolemia

Annual review of pharmacology and toxicology, 2014-01, Vol.54 (1), p.273-293

2014

Link zum Volltext

Verfügbarkeit prüfen

Small dense LDL and VLDL predict common carotid artery IMT and elicit an inflammatory response in peripheral blood mononuclear and endothelial cells

Atherosclerosis, 2009-10, Vol.206 (2), p.556-562

2009

Link zum Volltext

Verfügbarkeit prüfen

Emerging role of high density lipoproteins as a player in the immune system

Atherosclerosis, 2012-01, Vol.220 (1), p.11-21

2012

Link zum Volltext

Verfügbarkeit prüfen

Multifactorial Activation of NLRP3 Inflammasome: Relevance for a Precision Approach to Atherosclerotic Cardiovascular Risk and Disease

International journal of molecular sciences, 2020-06, Vol.21 (12), p.4459

2020

Link zum Volltext

Verfügbarkeit prüfen

High-Density Lipoprotein Subfractions - What the Clinicians Need to Know

Cardiology, 2013-01, Vol.124 (2), p.116-125

2013

Link zum Volltext

Verfügbarkeit prüfen

Nutraceuticals for Dyslipidaemia and Glucometabolic Diseases: What the Guidelines Tell Us (and Do Not Tell, Yet)

Nutrients, 2022-01, Vol.14 (3), p.606

2022

Link zum Volltext

Verfügbarkeit prüfen

Soluble Lectin-Like Oxidized Low Density Lipoprotein Receptor-1 as a Biochemical Marker for Atherosclerosis-Related Diseases

Disease markers, 2013-01, Vol.35 (5), p.413-418

2013

Link zum Volltext

Verfügbarkeit prüfen

Molecular Immune-Inflammatory Connections between Dietary Fats and Atherosclerotic Cardiovascular Disease: Which Translation into Clinics?

Nutrients, 2021-10, Vol.13 (11), p.3768

2021

Link zum Volltext

Verfügbarkeit prüfen

The Long Pentraxin PTX3: A Modulator of the Immunoinflammatory Response in Atherosclerosis and Cardiovascular Diseases

Trends in cardiovascular medicine, 2010-02, Vol.20 (2), p.35-40

2010

Link zum Volltext

Verfügbarkeit prüfen

miR-30c-5p regulates macrophage-mediated inflammation and pro-atherosclerosis pathways

Cardiovascular research, 2017-11, Vol.113 (13), p.1627-1638

2017

Link zum Volltext

Verfügbarkeit prüfen

Long Pentraxin 3: Experimental and Clinical Relevance in Cardiovascular Diseases

Mediators of Inflammation, 2013-01, Vol.2013, p.725102-10

2013

Link zum Volltext

Verfügbarkeit prüfen

Deficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis

Circulation (New York, N.Y.), 2009-08, Vol.120 (8), p.699-708

2009

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of the prescription of potentially interacting drugs

PloS one, 2013-10, Vol.8 (10), p.e78827

2013

Link zum Volltext

Verfügbarkeit prüfen

Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studies

Atherosclerosis, 2015-12, Vol.243 (2), p.449-461

2015

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum: The role of registers in increasing knowledge and improving management of children and adolescents affected by familial hypercholesterolemia: The LIPIGEN pediatric group

Frontiers in genetics, 2023-04, Vol.14, p.1113454-1113454

2023

Link zum Volltext

Verfügbarkeit prüfen

Real-World Effectiveness of PCSK9 Inhibitors in Reducing LDL-C in Patients With Familial Hypercholesterolemia in Italy: A Retrospective Cohort Study Based on the AIFA Monitoring Registries

Journal of the American Heart Association, 2023-11, Vol.12 (21), p.e026550-e026550

2023

Link zum Volltext

Verfügbarkeit prüfen

Proprotein Convertase Subtilisin Kexin 9 Inhibitors

Cardiology clinics, 2018-05, Vol.36 (2), p.241-256

2018

Link zum Volltext

Verfügbarkeit prüfen

MicroRNAs and lipoproteins: A connection beyond atherosclerosis?

Atherosclerosis, 2013-04, Vol.227 (2), p.209-215

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 177

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(167)
Mit Volltextzugriff
(163)

Publikationsform

Artikel
(176)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels

LOX-1, OxLDL, and Atherosclerosis

Vascular inflammation and low‐density lipoproteins: is cholesterol the link? A lesson from the clinical trials

Long pentraxin 3, a key component of innate immunity, is modulated by high-density lipoproteins in endothelial cells

Treating high density lipoprotein cholesterol (HDL-C): quantity versus quality

Post-prandial endothelial dysfunction in hypertriglyceridemic subjects: Molecular mechanisms and gene expression studies

Effects of PCSK9 variants on common carotid artery intima media thickness and relation to ApoE alleles

Targeting PCSK9 for hypercholesterolemia

Small dense LDL and VLDL predict common carotid artery IMT and elicit an inflammatory response in peripheral blood mononuclear and endothelial cells

Emerging role of high density lipoproteins as a player in the immune system

Multifactorial Activation of NLRP3 Inflammasome: Relevance for a Precision Approach to Atherosclerotic Cardiovascular Risk and Disease

High-Density Lipoprotein Subfractions - What the Clinicians Need to Know

Nutraceuticals for Dyslipidaemia and Glucometabolic Diseases: What the Guidelines Tell Us (and Do Not Tell, Yet)

Soluble Lectin-Like Oxidized Low Density Lipoprotein Receptor-1 as a Biochemical Marker for Atherosclerosis-Related Diseases

Molecular Immune-Inflammatory Connections between Dietary Fats and Atherosclerotic Cardiovascular Disease: Which Translation into Clinics?

The Long Pentraxin PTX3: A Modulator of the Immunoinflammatory Response in Atherosclerosis and Cardiovascular Diseases

miR-30c-5p regulates macrophage-mediated inflammation and pro-atherosclerosis pathways

Long Pentraxin 3: Experimental and Clinical Relevance in Cardiovascular Diseases

Deficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis

Prevalence of the prescription of potentially interacting drugs

Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studies

Corrigendum: The role of registers in increasing knowledge and improving management of children and adolescents affected by familial hypercholesterolemia: The LIPIGEN pediatric group

Real-World Effectiveness of PCSK9 Inhibitors in Reducing LDL-C in Patients With Familial Hypercholesterolemia in Italy: A Retrospective Cohort Study Based on the AIFA Monitoring Registries

Proprotein Convertase Subtilisin Kexin 9 Inhibitors

MicroRNAs and lipoproteins: A connection beyond atherosclerosis?

Suchergebnisse filtern